Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA02 - Novel Therapies in ROS1, HER2 and EGFR
- 10:30 - 12:00
- 9/24/2018
- Location: Room 105
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA02.01 - Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
10:30 - 10:40 | Presenter: Robert C. Doebele | Author(s): Myung-Ju Ahn, Salvatore Siena, Alexander Drilon, Matthew G Krebs, Chia-Chi Lin, Filippo G. De Braud, Thomas John, Daniel S.W. Tan, Takashi Seto, Rafal Dziadziuszko, Hendrick-Tobias Arkenau, Fabrice Barlesi, Christian Rolfo, Jürgen Wolf, Edna Chow-Maneval, Pratik S. Multani, Na Cui, Todd Riehl, Byoung Chul Cho
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-26 - Single-Centre Experience of Clinical Outcomes for Advanced Lung Cancer Patients in Phase I Clinical Trials.
16:45 - 18:00 | Presenter: Donna Marie Graham | Author(s): Thomas Jordan, Nadina Tinsley, Sreeja Aruketty, Alexander John Vickers, Claire Kelly, Roopa Kurup, Alison White, Amy Smith, Aisling Walsh, Chloe Thomson, Sinead O'Reilly, Michelle Norfolk, Dilshad Chang, Fiona Blackhall, Yvonne Summers, Raffaele Califano, Paul Taylor, Fiona Thistlethwaite, Natalie Cook, Louise Carter, Matthew G Krebs
- Abstract
Loading...
-
+
P2.04 - Immunooncology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.04-27 - Ph II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Pembrolizumab in Patients with Advanced NSCLC
16:45 - 18:00 | Presenter: James Lorens | Author(s): Carlos Arce-Lara, Edurne Arriola, Paal Brunsvig, Enric Carcereny, Manuel Domine, Konstantin Dragnev, Enriqueta Felip, Rosario García Campelo, Matthew G Krebs, Luis Paz-Ares, Santiago Ponce Aix, James Spicer, Jose Manuel Trigo, Nuria Vinolas Segarra, Robert Holt, David Micklem, Anthony Brown, Michael Chisamore
- Abstract
Loading...
-
+
P2.06 - Mesothelioma (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.06-09 - MiST3: A Phase II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Pembrolizumab in pts with Malignant Mesothelioma
16:45 - 18:00 | Presenter: Dean A Fennell | Author(s): Matthew G Krebs, Louise Carter, Shaun Villa, Amy King, Clare Massey, James Lorens, Emma Darlington
- Abstract
Loading...
-
+
P2.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.13-33 - A Case Report of Exceptional Clinical Response to MEK Inhibition in a Patient with NRAS Mutation Positive NSCLC
16:45 - 18:00 | Presenter: Donna Graham | Author(s): Matthew G Krebs, Mahmood Ayub, Jo Dransfield, Hannah Frost, Sreeja Aruketty, Bedirhah Kilerci, Andrew Wallace, Rajender Kamboj, Dhananjay Bakhle, Venkata Palle, Sharad Sharma, Narendra Maharaj, Rajesh Kumawat, Mandar Bhonde, Kristopher Frese, Caroline Dive, Dominic Rothwell, Ged Brady
- Abstract
Loading...